Creative Planning Grows Holdings in National Research Co. (NASDAQ:NRC)

Creative Planning lifted its stake in National Research Co. (NASDAQ:NRC) by 137.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,190 shares of the company’s stock after purchasing an additional 7,067 shares during the period. Creative Planning owned about 0.05% of National Research worth $280,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Algert Global LLC raised its position in National Research by 9.5% during the 2nd quarter. Algert Global LLC now owns 42,739 shares of the company’s stock valued at $981,000 after purchasing an additional 3,700 shares in the last quarter. Select Equity Group L.P. lifted its stake in National Research by 7.3% in the second quarter. Select Equity Group L.P. now owns 35,537 shares of the company’s stock worth $816,000 after acquiring an additional 2,408 shares during the period. Millennium Management LLC grew its holdings in National Research by 200.9% during the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock worth $4,931,000 after acquiring an additional 143,454 shares in the last quarter. Deerfield Management Company L.P. Series C increased its position in National Research by 107.0% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 18,620 shares of the company’s stock valued at $427,000 after purchasing an additional 9,626 shares during the period. Finally, AQR Capital Management LLC raised its holdings in shares of National Research by 18.9% in the 2nd quarter. AQR Capital Management LLC now owns 28,936 shares of the company’s stock valued at $664,000 after purchasing an additional 4,601 shares in the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Price Performance

NASDAQ NRC opened at $19.95 on Friday. The company has a market cap of $476.35 million, a PE ratio of 16.09 and a beta of 0.49. The firm’s 50 day moving average price is $21.23 and its 200-day moving average price is $25.88. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. National Research Co. has a 52-week low of $18.70 and a 52-week high of $43.98.

National Research (NASDAQ:NRC) last posted its earnings results on Tuesday, August 6th. The company reported $0.26 earnings per share for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The company had revenue of $35.02 million during the quarter.

National Research Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were paid a $0.12 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.48 annualized dividend and a yield of 2.41%. National Research’s dividend payout ratio (DPR) is presently 38.71%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.